U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313579) titled 'Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer' on Dec. 08, 2025.
Brief Summary: The study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.
Study Start Date: Dec. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Gastric Cancer (GC)
HIPEC
Peritoneal Metastases From Gastric Cancer
Hyperthermic Intraperitoneal Chemoperfusion
Intervention:
PROCEDURE: curative-intent surgery + HIPEC
Participants enrolled in this study will undergo cura...